A carregar...

Refsum's Disease—Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder

Refsum's Disease is an inherited metabolic disorder in which a metabolite of branched chain fatty acids accumulates due to lack of appropriate oxidative enzymes. Patients have elevated plasma phytanic acid levels and high concentrations of phytanic acid in a variety of tissues leading to progre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Perera, Nimalie J., Lewis, Barry, Tran, Huy, Fietz, Michael, Sullivan, David R.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2943115/
https://ncbi.nlm.nih.gov/pubmed/20871815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/482021
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!